Data as of Sep 18, 2026 · Based on 3,315,446 AI responses across 10,525 prompts · See how Parse measures this
RevealDx offers RevealAI-Lung, an AI-powered radiomics-based lung cancer decision-support software that non-invasively characterizes lung nodules to inform precision medicine. The platform provides actionable radiomic insights with a single-click calculation of the mSI metric, delivering results in seconds to help clinicians improve diagnostic confidence and reduce unnecessary procedures and costs. It has regulatory market authorizations for clinical use in multiple jurisdictions (FDA, CE, TGA, Health Canada; UK and New Zealand registrations) and partners with companies like 4DMedical and Azra AI to distribute and integrate its solution into oncology workflows.
Parse Score
